Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gusperimus in Refractory Wegener's Granulomatosis
NCT00530075Phase 2Completed
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Dec 2003
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of deoxyspergualin in granulomatosis with polyangiitis (GPA), sponsored by Nippon Kayaku Co., Ltd.. Started Dec 2003; status: completed.
02
Drugs
deoxyspergualin
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on NCT00530075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530075.